Hi Everyone,
I am writing today to ask about your institution's practice when dosing rivaroxaban for Afib. For Afib, there are two labeling recommendations based on CrCl: US and Canadian.
The Canadian labeling recommends avoiding use with CrCl < 30 mL/min. However, the US recommends avoiding use with CrCl < 15 mL/min.
Please let me know what labeling your institution follows when dosing rivaroxaban for Afib in patients with CrCl < 30 mL/min.
Thank you,